STMicroelectronics N.V. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data STMicroelectronics N.V. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	6,973	8,347	9,664	9,556	10,219	12,761	16,128	17,286	13,269	11,800
Cost of revenue	4,514	5,075	5,803	5,860	6,430	7,435	8,493	8,999	8,049	7,801
Gross profit	2,459	3,272	3,861	3,696	3,789	5,326	7,635	8,287	5,220	3,999
Research and development	1,331	1,296	1,398	1,498	1,548	1,723	1,901	2,100	2,077	2,044
Selling, general and administrative	907	981	1,095	1,093	1,109	1,323	1,454	1,631	1,649	1,632
Operating income	227	1,005	1,400	1,203	1,323	2,419	4,439	4,611	1,676	175
Interest expense	40	52	54	54	54	42	13	55	85	55
Interest income	20	30	47	55	34	13	71	226	303	223
Pre-tax income	201	953	1,389	1,189	1,267	2,337	4,486	4,763	1,878	400
Income tax	31	143	96	156	159	331	520	541	313	220
Net income to minority interests	5	8	6	1	2	6	6	11	8	14
Net income	165	802	1,287	1,032	1,106	2,000	3,960	4,211	1,557	166
EBITDA	923	1,655	2,191	2,057	2,246	3,464	5,655	6,172	3,436	2,029
EPS, basic	0.19	0.91	1.43	1.15	1.24	2.21	4.37	4.66	1.73	0.19
EPS, diluted	0.19	0.89	1.41	1.14	1.20	2.16	4.19	4.46	1.66	0.18
Shares, basic (weighted)	881	885	899	894	895	904	906	904	901	893
Shares, diluted (weighted)	886	906	911	904	920	925	946	944	939	923
Dividend per share							0.24	0.24	0.36	0.36

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	1,629	1,759	2,266	2,597	3,006	3,225	3,258	3,222	2,282	2,837
Short-term investments	335	431	330	133	133	0	679	1,635	2,452	985
Receivables	939	1,149	1,277	1,380	1,465	1,759	1,970	1,731	1,749	1,745
Inventory	1,173	1,335	1,562	1,691	1,841	1,972	2,583	2,698	2,794	3,136
Other current assets	311	425	419	442	584	581	734	1,295	1,007	1,468
Total current assets	4,387	5,099	5,854	6,257	7,610	7,828	9,805	11,807	11,734	11,271
Property, plant and equipment	2,287	3,094	3,495	4,007	4,596	5,660	8,201	10,554	10,877	11,058
Lease right-of-use assets				206	191	200	193	278	251	252
Goodwill	116	123	121	162	330	313	297	303	290	315
Intangible assets	195	209	212	299	445	438	405	367	346	324
Long-term investments	57	57	61	11	10	10	11	22	71	152
Other non-current assets	434	475	452	437	724	639	661	808	961	1,272
Total assets	8,004	9,681	10,867	11,868	14,454	15,540	19,982	24,453	24,743	24,800
Accounts payable	620	893	981	950	1,166	1,582	2,122	1,856	1,323	1,487
Accrued liabilities	750	897	874	831	966	1,101	1,385	1,525	1,306	1,440
Short-term debt	117	118	146	173	795	143	175	217	990	298
Total current liabilities	1,588	2,020	2,120	2,064	3,053	2,949	3,837	3,730	3,773	3,351
Long-term debt	1,334	1,583	1,764	1,899	1,826	2,396	2,542	2,710	1,963	1,835
Lease liabilities				152	142	148	141	188	160	169
Other non-current liabilities	134	215	160	330	488	416	454	735	904	926
Total liabilities	3,408	4,214	4,443	4,757	5,948	6,267	7,224	7,601	7,064	6,575
Total debt	1,451	1,701	1,910	2,072	2,621	2,539	2,717	2,927	2,953	2,133
Paid-in capital	2,818	2,718	2,843	2,992	3,062	2,533	2,631	2,866	3,088	3,281
Retained earnings	431	973	1,991	2,747	3,599	5,223	8,713	12,470	13,459	13,082
Treasury stock	-242	-132	-141	-328	-93	-200	-268	-377	-491	-637
Other comprehensive income	371	688	509	475	723	496	460	613	236	945
Shareholders' equity	4,535	5,404	6,359	7,043	8,448	9,209	12,693	16,729	17,449	17,828
Minority interests	61	63	65	68	58	64	65	123	230	397
Total equity	4,596	5,467	6,424	7,111	8,506	9,273	12,758	16,852	17,679	18,225
Total liabilities and equity	8,004	9,681	10,867	11,868	14,454	15,540	19,982	24,453	24,743	24,800
Shares outstanding	883	898	898	891	905	907	904	903	898	889

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	170	810	1,293	1,033	1,108	2,006	3,966	4,222	1,565	180
Depreciation and amortization	696	650	791	854	923	1,045	1,216	1,561	1,760	1,854
Stock-based compensation	38	61	125	145	155	221	215	236	222	193
Deferred income tax	-40	41	-18	25	-12	46	10	13	140	60
Change in receivables	-121	-206	-155	-103	-72	-307	-231	229	-32	5
Change in inventory	63	-94	-254	-142	-84	-188	-650	-72	-167	-172
Cash from operations	1,043	1,677	1,845	1,869	2,093	3,060	5,202	5,992	2,965	2,152
Acquisitions	-78			-127	-113
Purchases of investments	0	-99	-26	-3	-581	-17	-687	-10	-2,980	-354
Sales and maturities of investments	0	0	100	200		132	0	750	2,251	1,900
Cash from investing	-727	-1,468	-1,212	-1,172	-2,043	-1,518	-4,591	-5,766	-3,742	-43
Debt issued	13	7	281				200	329	300	0
Debt repaid	-191	-119	-103	-144	-184	-134	-134	-169	-203
Share buybacks		-297	-62	-250	-125	-485	-346	-346	-359	-367
Dividends paid	-251	-214	-216	-214	-168	-205	-212	-223	-288	-321
Cash from financing	-439	-106	-122	-343	348	-1,314	-567	-267	-155	-1,560
Exchange rate effect	-19	27	-4
Net change in cash	-142	130	507	341	399	219	33	-36	-940	555
Interest paid	13	12	12	13	7	2	2	31	67	54
Income taxes paid	42	52	60	130	138	279	416	489	197	141

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $52.74 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	33.9%	Gross profit / revenue.
Operating margin	1.5%	Operating income / revenue.
EBITDA margin	17.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.4%	Pre-tax income / revenue.
Net margin	1.4%	Net income / revenue.
Operating cash flow margin	18.2%	Cash from operations / revenue.
Effective tax rate	55.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	0.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.7%	Net income / average total assets.
Return on invested capital (ROIC)	0.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	17.3%	Research and development expense / revenue.
SG&A / revenue	13.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.6%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	15.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-11.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-9.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-23.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-19.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-89.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-66.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-33.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-40.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-28.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-2.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-89.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-65.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-31.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-89.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-65.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-31.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-27.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-25.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	0.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	14.5%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	2.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	16.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	11.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.36x	Current assets / current liabilities.
Quick ratio	1.66x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.14x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.12x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	8.6%	Total debt / total assets.
Liabilities / assets	26.5%	Total liabilities / total assets.
Net debt	-$1.69B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.83x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.18x	Operating income / interest expense.
Working capital	$7.92B	Current assets - current liabilities.
Goodwill and intangibles / assets	2.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$17.19B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.48x	Revenue / average total assets.
Fixed asset turnover	1.08x	Revenue / average property, plant and equipment.
Inventory turnover	2.63x	Cost of revenue / average inventory.
Days inventory	139 days	365 x average inventory / cost of revenue.
Receivables turnover	6.75x	Revenue / average receivables.
Days sales outstanding	54 days	365 x average receivables / revenue.
Days payables	66 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	127 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.18	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.19	Net income per basic share, as reported (split-adjusted).
Revenue per share	$12.78	Revenue / diluted weighted shares.
Operating cash flow per share	$2.33	Cash from operations / diluted weighted shares.
Book value per share	$20.06	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$19.34	Tangible book value / shares outstanding.
Cash per share	$4.30	(Cash + short-term investments) / shares outstanding.
Dividend per share	$0.36	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	193.4%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$47.07B	Share price x shares outstanding.
Enterprise value	$45.38B	Market cap + total debt - cash - short-term investments.
P/E	284x	Market cap / net income. Only when net income is positive.
P/S	3.99x	Market cap / revenue.
P/B	2.64x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.74x	Market cap / tangible book value, when positive.
P/OCF	21.9x	Market cap / cash from operations, when positive.
EV/Sales	3.85x	Enterprise value / revenue.
EV/EBIT	259x	Enterprise value / operating income, when both are positive.
EV/EBITDA	22.4x	Enterprise value / EBITDA, when both are positive.
Earnings yield	0.4%	Net income / market cap (the inverse of P/E).
Dividend yield	0.7%	Dividends paid over the period / market cap.
Shareholder yield	1.5%	(Dividends paid + share buybacks) / market cap.

What was STMicroelectronics N.V.'s revenue in fiscal 2025?

STMicroelectronics N.V. reported revenue of $11.80B for fiscal 2025, 11.1% lower than the year before.

Was STMicroelectronics N.V. profitable in fiscal 2025?

Yes. Net income was $166.0M, a net margin of 1.4%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to STMicroelectronics N.V.